FIELD: medicine, therapy, reflexotherapy.
SUBSTANCE: the innovation in question deals with carrying out combined intravenous and external laserotherapy in combination with complex medicinal impact upon the body. Additionally, it is important to fulfill monitor intestinal emptying, daily, about 6-8 procedures/course. External laserotherapy should be carried out onto corporal and auricular points. Medicinal therapy deals with introducing T-activin immunomodulators intramuscularly at the dosage of 100 mcg/d and Halavit at the dosage of 100 mg/d, about 10-20 procedures/course. It is important to apply Aciclovir at the dosage of 1 g/d, therapy course corresponds to 14. The intake of Eiconol in capsules at the dosage of 6-9/d, copper derivatives of chlorophyll at the dosage of 0.1g/d and food additive sodium alginate at the dosage of 4 g/d should be carried out during the whole therapy course. Intravenous and external laserotherapy should be fulfilled at about 8-10 procedures/course. The innovation normalizes cellular and humoral immunity, prolongs the aftereffects of therapy conducted and decreases the number of its complications.
EFFECT: higher efficiency of therapy.
3 cl, 4 dwg, 6 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ISCHEMIC STROKE PREVENTION ASSOSIATED WITH CHRONIC CEREBROVASCULAR INSUFFICIENCY OF ATHEROSCLEROTIC GENESIS | 2006 |
|
RU2329041C2 |
METHOD OF TREATMENT OF PATIENTS SUFFERING FROM ACUTE AND CHRONIC CEREBROVASCULAR DISEASES OF ATHEROSCLEROTIC GENESIS | 2006 |
|
RU2329042C2 |
METHOD OF TREATING PATIENTS WITH STABLE EXERTIONAL ANGINA | 2009 |
|
RU2401138C1 |
METHOD OF INTEGRATED TREATMENT OF PATIENTS WITH DISCIRCULATORY ENCEPHALOPATHY | 2011 |
|
RU2449822C1 |
METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
METHOD OF LIPID METABOLIC DISORDER CORRECTION | 2007 |
|
RU2337696C1 |
AGENT ELICITING ANTIHYPERLIPOPROTEINEMIC ACTIVITY, FOOD SUPPLEMENT BASED ON THEREOF AND METHOD OF TREATMENT OF LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2001 |
|
RU2201239C1 |
METHOD OF TREATING PATIENTS WITH METABOLIC SYNDROME | 2018 |
|
RU2699508C1 |
METHOD FOR GIVING PATIENTS POST-DISCHARGE ADJUSTMENT UNDER LOW- MOUNTAIN RESORT CONDITIONS AFTER CARDIOSURGICAL OPERATION | 2003 |
|
RU2261725C2 |
THERAPEUTICAL AGENT, USES THEREOF AND METHOD FOR DISEASES TREATMENT AND PROPHYLAXIS | 2005 |
|
RU2306144C1 |
Authors
Dates
2007-11-27—Published
2006-04-25—Filed